Sentara Infusion Services (Sentara Enterprises), Charlottesville, VA

Is Sentara Infusion Services (Sentara Enterprises) registered with the FDA as a 503B outsourcing facility?

No matching record found in FDA’s registered outsourcing facility list (updated Nov 6, 2026) on Nov 15, 2026, searching by name and location.

Does Sentara Infusion Services (Sentara Enterprises) hold a Virginia pharmacy license?

State pharmacy license records for Virginia are not checked: the Department of Health Professions’ license lookup is an interactive search form, which this index does not use. This index reads only that state’s board actions.

Has Sentara Infusion Services (Sentara Enterprises) had a state board action or FDA letter?

FDA letters: record found. FDA’s compounding inspections and actions page, current as of Oct 22, 2026, lists 1 state referral letter (Jan 26, 2024) and 1 FMD-145 letter (Jan 26, 2024) for Sentara Infusion Services (Sentara Enterprises). State board actions: no Virginia Board of Pharmacy action under this exact name and city was found in the Virginia Department of Health Professions’ list of Board of Pharmacy case decisions from the last 90 days (actions dated Aug 17, 2026 to Nov 15, 2026) on Nov 15, 2026. The state referral and handoff letters above are FDA’s letters to the state, not board actions.

FDA registers 503B outsourcing facilities; state boards of pharmacy license pharmacies, including 503A compounding pharmacies, and keep their own disciplinary records. Neither FDA list says which drugs a pharmacy makes.

Names in FDA records
Sentara Enterprises; Sentara Infusion Services
Location
Charlottesville, VA
Type as FDA labels it
Not stated
FDA 503B list
No matching record found
Form 483s on FDA’s actions page
1
Warning letters on FDA’s actions page
0
Latest action on that page
Jan 26, 2024
FDA Data Dashboard inspections
1 inspection: 1 VAI; 1 published Form 483
Form 483 text on this page
1 Form 483, 5 observations
State board records
Not checked (license records); board actions matched: 0

FDA inspections and letters

FDA’s compounding inspections and actions page (current as of Oct 22, 2026) lists this pharmacy as Sentara Enterprises dba Sentara Infusion Services, with 3 dated actions.

Document
Jan 26, 2024FMD-145 letterFMD-145 Letter Issued 01/26/2024Not linked by FDA
Jan 26, 2024State referral letterState Referral Letter Issued 01/26/2024FDA copy (archived)
Jul 14, 2023Form 483483 Issued 7/14/2023FDA copy (archived)

A Form 483 lists investigator observations, not a final FDA determination. An untitled or FMD-145 letter states FDA’s view when it was issued.

FDA inspection classifications and published Form 483s

The FDA Data Dashboard, read Nov 15, 2026, lists Sentara Enterprises, Charlottesville, VA (FEI number 3025984445), matched to this page by exact name, city and state. It lists 1 inspection: 1 VAI at that site, newest first, with FDA’s classification as worded on the dashboard. Dashboard firm profile.

Inspection endedClassificationProject area and product typeFEIInspection ID
Jul 14, 2023Voluntary Action Indicated (VAI)Drug Quality Assurance (Drugs)30259844451210216

Form 483s FDA has published for this site

FDA classifies each inspection when it is closed: No Action Indicated (NAI) means no objectionable conditions were found or they did not justify further action; Voluntary Action Indicated (VAI) means objectionable conditions were found but FDA is not prepared to take or recommend regulatory action; Official Action Indicated (OAI) means FDA recommended regulatory or administrative action. A classification is FDA’s, not a finding by this site. The dashboard lists inspections once FDA has classified them, from fiscal year 2009 on, so a recent inspection may not appear yet.

Form 483 observations

A Form 483 lists an FDA investigator’s observations at the end of an inspection. It is not a final FDA determination. In FDA’s words: “The FDA Form 483 does not constitute a final Agency determination of whether any condition is in violation of the FD&C Act or any of its relevant regulations.” (FDA Form 483 FAQ). The firm may have answered or corrected these points; a response is not shown here unless FDA lists one.

FDA’s published Form 483 for this site has 5 numbered observations in all. Each observation is quoted from the PDF as FDA numbered it. Names of people on the form are not shown. What a Form 483 is; all 483s in this index.

Inspection Jul 6, 2023 to Jul 14, 2023: 5 observations

Firm on the cover
Sentara Enterprises dba Sentara Infusion Services (Blue Ridge), 920 E High St, Charlottesville, VA 22902-4 850
FEI number
3025984445
Establishment type on the cover
Producer of Sterile Drug Products
FDA district office on the cover
11155 Dolfield Boulevard, Suite 117 Owings Mills, MD 21117
Matched to this page by
FEI number on the cover; linked from Data Dashboard
FDA document
Read the full 483 (PDF on fda.gov)

Observation 1

Personnel were observed conducting aseptic manipulations where the movement of "first air" in the ISO 5 area is blocked or disrupted.

Specifically, on July 11, 2023 while Technician was working in ISO 5 classified <Redacted B4> laminar airflow hood <Redacted B4> equipment ID <Redacted B4>, producing MYCAMINE l 00MG IN l00ML HOMEPUMP Rx <Redacted B4> was observed blocking first pass air with left hand (holding small vial) while making aseptic connections.

Observation 2

Personnel performed aseptic manipulations with exposed hair or skin.

Specifically, on July 11, 2023, while Technician <Redacted B4> was working in ISO 5 classified <Redacted B4> laminar airflow hood (equipment ID <Redacted B4> producing SOLUMEDROL lGM IN NS l 00ML Rx <Redacted B4> HOMEPUMP , • was observed leaning into ISO 5 classified <Redacted B4> laminar airflow hood with exposed skin (around eyes and forehead) while making aseptic connections.

Observation 3

Lack of disinfection of supplies at each transition from areas of lower quality air to areas of higher quality air.

Specifically, on July 11, 2023, while Technician was observed working in ISO 5 classified <Redacted B4> laminar airflow hood s, (equipment ID <Redacted B4>, producing SODillM CHLORIDE 0.9% 2000ML Rx # <Redacted B4> was observed introducing sterile IP A bottle into ISO 5 classified <Redacted B4> laminar antlow hood without sanitizing the outer surface.

Observation 4

Failure to conduct media fills that closely simulate aseptic production operations under the worst-case, most-challenging, and stressful conditions.

Specifically, your media fills do not include representative container-closure types (elastomeric pumps and large IV bags), equipment <Redacted B4> automated compounding device) and the quantity and volume of finished drug products per order.

Observation 5

Smoke studies were inadequately performed under dynamic conditions.

Specifically, unidirectional airflow was not verified under dynamic conditions representative of your typical production process. Smoke studies conducted in May 2023 in your ISO 5 laminar air flow hoods equipment ID# <Redacted B4> did not show manipulations or conditions performed <Redacted B4> automated compounding device or repeater pump in use) that would be representative of the ~ dynarmc process used in actual production processes.

Linked 483s whose text is not shown

State board of pharmacy records

State pharmacy license records for Virginia are not checked: the Department of Health Professions’ license lookup is an interactive search form, which this index does not use. This index reads only that state’s board actions. Board actions source.

What this covers: Board of Pharmacy case decisions the Department of Health Professions lists as entered in the last 90 days, worded as it gives them. Older decisions are reachable only through a search form, which this index does not use, so only that 90-day window is checked. The orders themselves sit behind a disclaimer form and are not linked. Virginia pharmacy licenses are not checked. Actions in the data are dated Aug 17, 2026 to Nov 15, 2026.

Same name at other locations

FDA lists these records under the same name at another location. A shared name does not establish that they are the same firm.

This page restates FDA’s lists and state board of pharmacy records. A Form 483, letter or board action is not a finding by this site, and a missing record is not a finding either way. A state license is matched only on the same name, city and state. Follow each link for the original document. Report an error or add a company response.

Sources

Records last pulled Nov 15, 2026. Every entry links to the original public record.